Attached files
| file | filename |
|---|---|
| EX-31 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - QUANTRX BIOMEDICAL CORP | ex31.htm |
| EX-10.1 - EXHIBIT 10.1 - QUANTRX BIOMEDICAL CORP | ex10-1.htm |
| 10-Q - QUARTERLY REPORT - QUANTRX BIOMEDICAL CORP | qtxb_10qsep302018.htm |
Exhibit 32
CERTIFICATION PURSUANT TO 18 U.S.C. §1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying
Quarterly Report on Form 10-Q of QuantRx Biomedical Corporation
(the “Company”) for the period ending September 30, 2018,
as filed with the Securities and Exchange Commission on or about
the date hereof (the “Report”), the undersigned, Shalom Hirschman,
Principal Executive and Principal Financial and Accounting Officer
of the Company, certifies, to my best knowledge and belief,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:
|
|
(1)
|
The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended;
and
|
|
|
|
|
|
|
(2)
|
The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations
of the Company.
|
|
Date: November 19, 2018
|
/s/ Shalom Hirschman
|
|
|
Shalom Hirschman
Principal Executive, Financial and Accounting Officer
|